Streamlining submissions for faster drug approvals

The development of vaccines for COVID-19 made clear the value of being first to market. Pharmaceutical companies that optimize their drug-submission process can expedite the approval timeline from an average of about eight months by collaborating with regulators and simplifying strategies.

Regulatory filing for pharmaceutical companies typically takes about eight  to nine months.

To read the article, see “Getting strategic about new-product submissions in the pharma industry,” September 16, 2021.